To develop PET tracers for imaging of Alzheimer's disease, new carbon-11 labeled potent and selective PDE5 inhibitors have been synthesized. The reference standards (5) and (12), and their corresponding desmethylated precursors (6) and (13) were synthesized from methyl 2-amino-5-bromobenzoate and (4-methoxyphenyl)methanamine in multiple steps with 2%, 1%, 1% and 0.2% overall chemical yield, respectively. The radiotracers ([C]5) and ([C]12) were prepared from their corresponding precursors 6 and 13 with [C]CHOTf through O-C-methylation and isolated by HPLC combined with SPE in 40-50% radiochemical yield, based on [C]CO and decay corrected to EOB. The radiochemical purity was >99%, and the molar activity (A) at EOB was in a range of 370-740 GBq/μmol.